Deciphera Pharmaceuticals announced that it has appointed Christopher J. Morl, M.B.A., as its Chief Business Officer. In this newly created role, Mr. Morl, who has more than 25 years of experience as a senior executive in the biotechnology and pharmaceutical industry, will be responsible for corporate and business development initiatives, as well as corporate and product strategic planning. Prior to joining Deciphera Pharmaceuticals, Mr. Morl served as Chief Operating Officer and previously as Chief Business Officer at miRagen Therapeutics Inc.